NCT05818839

Brief Summary

This study aimed to investigate the differences in the biomechanical properties of the dorsal trunk and lower extremity muscles of children with unilateral spastic cerebral palsy compared with their typically developing peers, and the effect of these biomechanical properties on balance and functional mobility performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

April 6, 2023

Last Update Submit

April 18, 2023

Conditions

Keywords

postural balancemuscle propertiesmobilityparalysischildren

Outcome Measures

Primary Outcomes (6)

  • The Pediatric Balance Scale

    The Pediatric Balance Scale assesses functional balance in three categories: self-care, mobility and social function, using 14 items. Each item is scored from 0 (indicating low function) to 4 (indicating highest function), with a maximum score of 56 points. A higher score indicates better balance.

    Baseline

  • Trunk Control Measurement Scale

    The TCSM was used to assess seated trunk balance and consisted of 15 items. Each item was scored from 0 to 3, with 0 indicating inability to perform the task and 3 indicating the full performance of the item. A high score indicated good trunk control

    Baseline

  • 2-Minute Walk Test

    The children were asked to walk at a normal pace, without running, and the distance they walked for 2 minutes was recorded.

    Baseline

  • Timed Up and Go Test

    The children were seated with their feet in full contact with the floor, in a chair with back support only, and with their hip and knee joints at 90 degrees. On the start command, they were asked to walk 3 metres to the wall at a pace they felt comfortable with and then sit back down in the chair.

    Baseline

  • Muscle tone (Hz)

    The muscle tone which is a biomechanical property of the muscles evaluated with a portable hand-held myotonometer. This myotonometer (MyotonPRO - Tallinn, Estonia) is non-invasive and provides a quantitative assessment of a muscle's biomechanical properties. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle or facia. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.

    Baseline

  • Stiffness (N/m)

    The stiffness which is a biomechanical property of muscles will be evaluated with a portable hand-held myotonometer. This myotonometer (MyotonPRO - Tallinn, Estonia) is non-invasive and provides a quantitative assessment of a muscle's biomechanical properties. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle or facia. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.

    Baseline

Study Arms (2)

UCP

Children diagnosed with unilateral spastic cerebral palsy

TyD

Typically developing children

Eligibility Criteria

Age4 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children diagnosed with unilateral spastic cerebral palsy (GMFCS level I-II, spasticity level MAS ≤ 2) and their age-matched typically developing peers.

You may qualify if:

  • aged between 4 and 12 years,
  • spasticity level MAS≤2,
  • mental level sufficient to understand commands given,
  • and ambulation without the use of an orthosis or other device. In addition, children had to be GMFCS level I or II.

You may not qualify if:

  • a history of spinal surgery or spinal orthosis use,
  • uncorrected vision or hearing problems,
  • severe epileptic seizures,
  • lower extremity contractures,
  • botulinum toxin A injection in the previous six months,
  • lower extremity surgery in less than one year,
  • use of pharmacological agents that affect muscle tone,
  • and poor cooperation.
  • aged between 4 and 12 years,
  • no neurological or orthopaedic diagnosis,
  • no known systemic problems,
  • normal vision and hearing,
  • and a mental level sufficient to understand the commands given.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Okan University

Istanbul, 34959, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral PalsyParalysis

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Co-Investigator

Study Record Dates

First Submitted

April 6, 2023

First Posted

April 19, 2023

Study Start

July 1, 2022

Primary Completion

November 20, 2022

Study Completion

February 20, 2023

Last Updated

April 19, 2023

Record last verified: 2023-04

Locations